SCHEMBL5481480

SCHEMBL5481480

Cc1ccc(N=C=O)c(I)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.45
TRPA1 O75762 1/20 0.44
ALDH1A1 P00352 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
HPGD P15428 1/20 0.42
CYP1A2 P05177 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
ATM Q13315 1/20 0.32
ADRA2A P08913 1/20 0.32
GAA P10253 1/20 0.32
CYP2A6 P11509 2/20 0.31
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30519851 0.81 CYP3A4 (0.50) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL645833 0.81 CYP3A4 (0.50) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL29123916 0.80 APLNR (0.36) CYP3A4ALDH1A1TDP1HPGDCYP1A2
SCHEMBL31115173 0.79 CYP3A4 (0.52) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL627870 0.79 CYP3A4 (0.52) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL608937 0.79 CYP3A4 (0.48) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL31115174 0.79 CYP3A4 (0.52) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL27900891 0.78 CYP3A4 (0.47) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL3841180 0.76 CYP3A4 (0.45) CYP3A4TRPA1ALDH1A1TDP1HPGD
SCHEMBL11667358 0.76 CYP3A4 (0.48) CYP3A4TRPA1ALDH1A1TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114040934-A Polymerizable composition for producing polyisocyanurate-based plastics having extended pot life 科思创知识产权两合公司 2022-02-11 CN disclosed
EP-2246333-B1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors ABBOTT LAB (US) 2012-10-24 EP disclosed
US-20070135387-A1 Inhibitors of protein kinases ABBOTT LABORATORIES 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135387-A1 Inhibitors of protein kinases MAP3K20, PACSIN2, MAP4K2 CYP3A4 4628/4885TRPA1 4486/4885ALDH1A1 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.